Skip to main content
Log in

Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Introduction

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by café-au-lait spots, neurofibromas, skinfold freckles, Lisch nodules, bone deformities, learning disabilities, and predisposition to neoplasms. It is caused by various mutations of the NF1 gene. Recently a 3-bp in-frame deletion in exon 17, c.2970-2972 delAAT mutation, has been associated with a milder phenotype of NF1 manifesting with pigmentary skin changes only.

Materials and methods

We therefore analyzed 35 NF1 patients without neurofibromas, learning problems, or bone lesions (19 familial, 16 sporadic, age 7–44 years) for exon 17 mutations by DNA sequencing.

Results

We did not find the c.2970-2972 delAAT mutation in this group but identified two base changes in exon 17 (c.2989A>G and c.2894T>A), whether these two novel mutations are related to a mild phenotype remains to be confirmed in further studies. Our results suggest the reported phenotypic associations may not be valid for all populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cutting LE, Levine TM (2010) Cognitive profile of children with neurofibromatosis and reading disabilities. Child Neuropsychol 16:417–432

    Article  PubMed  Google Scholar 

  2. Han SS, Cooper DN, Upadhyaya MN (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109:487–497

    Article  PubMed  CAS  Google Scholar 

  3. Jeong SY, Park SJ, Kim HJ (2006) The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. J Korean Med Sci 21:107–112

    Article  PubMed  CAS  Google Scholar 

  4. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  5. (1988) Neurofibromatosis: conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45: 575–578

  6. North K, Hyman S, Barton B (2002) Cognitive deficits in neurofibromatosis 1. J Child Neurol 17:605–612

    Article  PubMed  Google Scholar 

  7. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D, members of the NF France Network (2010) NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31(6):E1506–E1518

    Article  PubMed  CAS  Google Scholar 

  8. Terzi YK, Oguzkan S, Anlar B, Aysun S, Ayter S (2007) Neurofibromatosis: novel and recurrent mutations in Turkish patients. Pediatr Neurol 37:421–425

    Article  PubMed  Google Scholar 

  9. Tonsgard JH, Yelavarthi KK, Cushner S, Short MP, Lindgren V (1997) Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 73:80–86

    Article  PubMed  CAS  Google Scholar 

  10. Trovó-Marqui AB, Goloni-Bertollo EM, Valério NI, Pavarino-Bertelli EC, Muniz MP, Teixeira MF, Antonio JR, Tajara EH (2005) High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1. Braz J Med Biol Res 38:1441–1447

    Article  PubMed  Google Scholar 

  11. Trovó-Marqui AB, Tajara EH (2006) Neurofibromin: a general outlook. Clin Genet 70:1–13

    Article  PubMed  Google Scholar 

  12. Upadhyaya M, Cooper DN (1998) The mutational spectrum in neurofibromatosis 1 and its underlying mechanisms. In: Upadhyaya M, Cooper DN (eds) Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific, Oxford, pp 65–88

    Google Scholar 

  13. Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype–phenotype correlation. Am J Hum Genet 80:140–151

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank to all the families who participated in this work. This study was supported by Hacettepe University Scientific Research Foundation (06 01 101 021).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sukriye Ayter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terzi, Y.K., Sirin, B., Serdaroglu, E. et al. Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype. Childs Nerv Syst 27, 2113–2116 (2011). https://doi.org/10.1007/s00381-011-1512-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-011-1512-z

Keywords

Navigation